The Global Vascular Graft Market is growing at a high CAGR of 7.3% during the forecast period (2022-2029).
Avascular graft (or) vascular bypass is a surgical procedure that is used to redirect blood flow from one area to another by reconnecting blood vessels, also known as a channel used to replace the diseased or blocked blood vessels. It can be arteries, veins, or capillaries. Vascular grafts have their application in treating cardiovascular diseases, kidney failure, vascular occlusion, and others.
The global vascular graft market growth is driven by the rise of cardiovascular diseases, coronary artery diseases, diabetes, and the requirement for artificial vessel implantations.
Increasing incidence of ESRD will drive the market growth
According to the University of California, approximately 2 million people worldwide suffer from ESRD. Annually, ESRD affects around 650,000 people in the US. Japan, Taiwan, Mexico, the US, and Belgium currently have the highest prevalence of ESRD. The only alternative to kidney transplantation is dialysis, which is frequently used by patients with ESRD. Hemodialysis treatment is done three times per week. Because of prolonged dialysis, the superficial veins of many patients are exhausted, and vascular grafts remain the only option to allow continued hemodialysis. Also, according to the National Institute of Diabetes and Digestive and Kidney Diseases (2016), the overall prevalence of CKD in the US is ~14%. More than 0.6 million Americans have kidney failure. Of these, 0.4 million individuals are on dialysis.
Apart from the mentioned factors, genetic and hereditary factors, unhealthy lifestyle, alcohol consumption, and tobacco smoking, among others are expected to increase the demand for vascular grafts over the period.
Download Sample Brochure @ https://www.datamintelligence.com/download-sample/vascular-graft-market
- Haemodialysis Access Graft
- Endovascular Aneurysm Repair Stent Graft
- Peripheral Vascular Graft
By Raw Material
- Polytetrafluoroethylene (PTFE)
The vascular graft market is a moderately competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Abbott Laboratories, Braun Melsungen AG, Bard Peripheral Vascular Inc. (BD), Cardinal Health (Cordis Corporation), Cook Medical, Cryolife, Getinge Group, LeMaitre Vascular Inc, Medtronic PLC, Terumo Medical Corporation, W.L. Gore & Associates Inc among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the vascular graft market globally. For instance, in October 2017, Medtronic developed Endurant II Stent Graft System to treat AAA The Endurant II Stent Graft System is placed into the abdominal aneurysm to provide an alternative channel for the flow of blood.
DataM Intelligence was established on an elemental idea of publishing Advanced Market Research Reports with precise data points & utmost accuracy that will accelerate the decision-making in designing disruptive solutions.